SCHEMBL30612169

SCHEMBL30612169

COCCn1ccc2c(C=O)cc(Cl)nc21

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GLO1 Q04760 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ PTGER4 P35408 1/20 0.34
▸ POLB P06746 2/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ CNR2 P34972 2/20 0.31
▸ CNR1 P21554 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ MTNR1A P48039 2/20 0.31
▸ MTNR1B P49286 2/20 0.31
▸ CTSS P25774 1/20 0.30
▸ MAOB P27338 1/20 0.30
▸ LRRK2 Q5S007 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ GRIN2B Q13224 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26107263 1.00 GLO1 (0.35) GLO1ALDH1A1PTGER4POLBTDP1
SCHEMBL26105147 0.82 CYP19A1 (0.32) ALDH1A1PTGER4HSP90AA1MEN1KMT2A
SCHEMBL30611846 0.82 CYP19A1 (0.32) ALDH1A1PTGER4HSP90AA1MEN1KMT2A
SCHEMBL26107392 0.81 LTA4H (0.36) MAOB
SCHEMBL26105455 0.81 HRH4 (0.31) HSP90AA1
SCHEMBL30612157 0.81 HRH4 (0.31) HSP90AA1
SCHEMBL26105860 0.79 SLC2A1 (0.37) —
SCHEMBL31347169 0.79 SLC2A1 (0.37) —
SCHEMBL30611847 0.78 CYP2A6 (0.36) ALDH1A1TDP1MEN1KMT2A
SCHEMBL26106551 0.78 CYP2A6 (0.36) ALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585252-A Bicyclic heteroaryl containing compounds as IKZF2 degrading agents 翁科皮亚治疗公司和SK生命科学实验室 2025-03-07 — — CN disclosed
EP-4499629-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) 2025-02-05 — — EP disclosed
WO-2023183919-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS ONCOPIA THERAPEUTICS, INC. D/B/A PROTEOVANT THERAPEUTICS, INC. (US) 2023-09-28 — — WO disclosed
Send feedback